Risk factor
Good trading liquidity
Profitability factor
Greatly overvalued vs peers
About
Guolian Securities Co., Ltd., together with its affiliated entities, offers a comprehensive range of financial products and services throughout the People's Republic of China. The company structures its operations into distinct divisions: Brokerage and Wealth Management, Credit Transactions, Investment Banking, Proprietary Trading, and Asset Management and Investment. Its extensive service offerings include traditional securities trading and brokering. It also provides financial leverage facilities for brokerage clients, offers lending collateralized by securities, and manages securities repurchase agreements. For institutional clients, the firm delivers corporate finance solutions and expert financial advisory, alongside functioning as a market maker. Moreover, Guolian Securities actively distributes wealth management products and engages in direct investments, in addition to managing various investment funds. Its capabilities further extend to providing complete management and maintenance services, investment consultation and advice, transaction execution, and strategic asset allocation. The company is deeply involved in the underwriting and sponsorship of both securities and bonds, undertakes investment management activities, and makes proprietary investments across venture capital, industrial ventures, and equity holdings. Furthermore, it delivers asset management services, acts as an introducing broker for futures companies, facilitates margin financing and securities lending, and distributes financial products on behalf of other brokers. As of December 31, 2021, Guolian Securities maintained a significant physical presence with 101 locations, specifically 13 main branch offices and 88 securities branches. Founded in 1992, the company was originally named Wuxi Securities Co., Ltd. It subsequently rebranded to Guolian Securities Co., Ltd. in May 2008. Its corporate headquarters are located in Wuxi, within the People's Republic of China.
Company Valuation
Considering past and projected metrics, the stock is distinctly 'expensive' compared to its peers. In particular, the stock is overpriced on P/E, 'expensive' on EV/EBITDA